Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs

被引:40
作者
Garcia-Moreno, Elena [1 ]
Gascon, Sonia [2 ]
Atrian-Blasco, Elena [1 ]
Jesus Rodriguez-Yoldi, Ma [2 ]
Cerrada, Elena [1 ]
Laguna, Mariano [1 ]
机构
[1] Univ Zaragoza, CSIC, Inst Sintesis Quim & Catalisis Homogenea, Dept Quim Inorgan, E-50009 Zaragoza, Spain
[2] Univ Zaragoza, Fac Vet, Unidad Fisiol, Dept Farmacol & Fisiol,CIBERobn, E-50013 Zaragoza, Spain
关键词
Gold; Thiolate; Water soluble; PTA; Antitumor properties; THIOREDOXIN REDUCTASE INHIBITION; METAL-BASED CHEMOTHERAPY; IN-VITRO CYTOTOXICITY; ANTITUMOR-ACTIVITY; PHOSPHINE COMPLEXES; COORDINATION-COMPLEXES; RHEUMATOID-ARTHRITIS; THERAPEUTIC AGENTS; CARBENE COMPLEXES; TROPICAL DISEASES;
D O I
10.1016/j.ejmech.2014.04.001
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
New stable thiolate gold(I) derivatives containing the alkylated phosphanes [PTA-CH2Ph]Br and [PTA -CH2COOMe]Br derived from 1,3,5-triaza-7-phosphaadamantane (PTA) have been prepared by different routes of synthesis. By the use of basic media to deprotonate the corresponding thiol in the former and by transmetallation reactions from tin (IV) complexes, in the later, thus avoiding side reactions on the phosphane. Strong antiproliferative effects are observed for most of the compounds, including the chloro-and bromo precursors with the series of phosphanes derived from PTA, in human colon cancer cell lines (Caco-2, PD7 and TC7 clones). Apoptosis-induced cell death is found for all compounds, being the thiolate derivatives with [PTA-CH2Ph]Br the most effective, as shown by an annexin-V/propidium iodide double-staining assay. (c) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:164 / 172
页数:9
相关论文
共 64 条
[1]
A new family of sulfur-rich ligands based on the dmit system:: synthesis and metal complexation of 4-4′-covalently bridged bis(2-thioxo-1,3-dithiol-5-thiolato) units [J].
Allen, DW ;
Berridge, R ;
Bricklebank, N ;
Cerrada, E ;
Light, ME ;
Hursthouse, MB ;
Laguna, M ;
Moreno, A ;
Skabara, PJ .
JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 2002, (13) :2654-2659
[2]
Targeting the mitochondrial cell death pathway with gold compounds [J].
Barnard, Peter J. ;
Berners-Price, Susan J. .
COORDINATION CHEMISTRY REVIEWS, 2007, 251 (13-14) :1889-1902
[3]
Structural and solution chemistry of gold(I) and silver(I) complexes of bidentate pyridyl phosphines: selective antitumour agents [J].
Berners-Price, SJ ;
Bowen, RJ ;
Galettis, P ;
Healy, PC ;
McKeage, MJ .
COORDINATION CHEMISTRY REVIEWS, 1999, 185-6 :823-836
[4]
Gold compounds as therapeutic agents for human diseases [J].
Berners-Price, Susan J. ;
Filipovska, Aleksandra .
METALLOMICS, 2011, 3 (09) :863-873
[5]
Bioinorganic and medicinal chemistry: aspects of gold(I)-protein complexes [J].
Bhabak, Krishna P. ;
Bhuyan, Bhaskar J. ;
Mugesh, Govindasamy .
DALTON TRANSACTIONS, 2011, 40 (10) :2099-2111
[6]
Thioredoxin reductase: A target for gold compounds acting as potential anticancer drugs [J].
Bindoli, Alberto ;
Rigobello, Maria Pia ;
Scutari, Guido ;
Gabbiani, Chiara ;
Casini, Angela ;
Messori, Luigi .
COORDINATION CHEMISTRY REVIEWS, 2009, 253 (11-12) :1692-1707
[7]
CARMICHAEL J, 1987, CANCER RES, V47, P936
[8]
Casini A., 2013, J INORGANIC BIOCH, V109, P97
[9]
Exploring the mechanisms of metal-based pharmacological agents via an integrated approach [J].
Casini, Angela .
JOURNAL OF INORGANIC BIOCHEMISTRY, 2012, 109 :97-106
[10]
Ortho-metalated benzenethiolate bridging dinuclear palladium(II) complexes.: X-ray structures of [Sn2(μ-C6H4S)2(tBu)4] and [Pd2(μ-C6H4S)(μ-dppm)2Cl2] [J].
Cera, M ;
Cerrada, E ;
Laguna, M ;
Mata, JA ;
Teruel, H .
ORGANOMETALLICS, 2002, 21 (01) :121-126